Medicinal Cannabis Prescriber Education

Learn

Medicinal Cannabis Clinical Data and Research

Cannasouth is supporting healthcare providers by providing medicinal cannabis prescriber education, and clinical data for specialists, doctors and clinicians.

The Cannasouth Clinical Fact Finder™ is where you can quickly and easily find clinical evidence on the use of medicinal cannabis. You can search and find open source studies on the most common symptoms for which medicinal cannabis is used. There are also reviews undertaken by Heath Agencies around the world on medical cannabis and its use in clinical practice.

These tools provide an opportunity for clinicians to increase their understanding of the ECS and how the endocannabinoid system’s functionality is able to be supported by phytocannabinoids. Our aim is to help medical professionals and health care practitioners gain important knowledge on these subjects to give them confidence in prescribing medical cannabis for patients.

 

Clinical Fact Finder

Select a topic to view research:

+ Pain

Indication
Title
Cannabinoids
Type
Patients
Year
Open Source
Chronic/Neuropathic Pain
Medical Cannabis for Neuropathic Pain
THC (plant)
Systematic Review
N/A
2018
Chronic/Neuropathic Pain
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases
THC, THC:CBD
Systematic Review
N/A
2018
Chronic/Neuropathic Pain
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
THC, CBD, Nabilone, Dronabinol, THC:CBD
Systematic Review
1,334
2017
Chronic/Neuropathic Pain
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
THC, THC (plant), Nabilone, Dronabinol, THC-11-oic Acid
Systematic Review
766
2011
Chronic/Neuropathic Pain
Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
THC (plant)
DB, PC, CO
39
2013
Chronic/Neuropathic Pain
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
THC (plant)
R, DB, PC, CO
21
2010
Chronic/Neuropathic Pain
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
Dronabinol
R, DB, PC, CO, Phase 1
30
2008
Chronic/Neuropathic Pain
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
THC (plant)
DB, PC, CO
38
2008
Chronic/Neuropathic Pain
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies
THC, CBD, THC:CBD
R, DB, PC, CO
34
2004
Chronic/Neuropathic Pain
Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury
Dronabinol
66
2020
Chronic/Neuropathic Pain
Effects of cannabinoid administration for pain
THC
Meta-Analysis
N/A
2019
Chronic/Neuropathic Pain
A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
THC:CBD
Clinical Trial
70
2012
Fibromyalgia
Safety and Efficacy of Medical Cannabis in Fibromyalgia
THC, CBD
Observational Study
211
2019
Fibromyalgia
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia
THC, CBD, THC:CBD
R, DB, PC, CO
20
2019
IBD
Medical Cannabis: An Option for the Treatment of IBD & Colon Cancer?
THC, CBD, THC/CBD
Review
N/A
2018
IBD
Cannabis Induces a Clinical Response in Patients With Crohn’s Disease: A Prospective Placebo-Controlled Study
THC
PC, Prospective Cohort Study
21
2013
Multiple
Role of the cannabinoid system in pain control
THC/CBD
Mode of Action
N/A
2006

+ Palliative Care

Indication
Title
Cannabinoids
Type
Patients
Year
Open Source
Cancer
Cannabis and Cannabinoids (PDQ®)–Health Professional Version (National Cancer Institute)
THC, CBD, Dronabinol, THC:CBD
Systematic Review
N/A
2020
Cancer
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain
THC, THC:CBD
Systematic Review
N/A
2019
Cancer
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
THC, CBD, THC:CBD
Systematic Review
N/A
2019
Cancer
Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain
THC:CBD, Nabiximols
R, DB, PC, Phase 3
397
2018
Cancer
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Nabiximols
R, DB, PC
263
2012
Cancer
Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related Pain
THC, THC:CBD
R, DB, PC, PG
177
2010
Cancer
Nabilone Versus Prochlorperazine for Control of Cancer Chemotherapy-Induced Emesis in Children: A Double-Blind, Crossover Trial
Nabilone
R, DB, CO
30
1987
General
Cannabis in palliative care: current challenges and practical recommendations
THC, CBD, Dronabinol, THC:CBD
Systematic Review
N/A
2018
HIV
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
THC (plant)
DB, PC, CO, Phase 2
N/A
2009
HIV
Cannabis in painful HIV-associated sensory neuropathy
THC
R, PC
50
2007
Summaries
Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand
CBD
Review
400
2020
Summaries
Therapeutic Effects of Cannabis and Cannabinoids
THC, CBD, THC/CBD
Review
N/A
2017

+ Neurological

Indication
Title
Cannabinoids
Type
Patients
Year
Open Source
Anxiety
Effects of Marijuana on Mental Health: Anxiety Disorders
THC, CBD, THC:CBD
Systematic Review
N/A
2017
Anxiety
CBD as a Potential Treatment for Anxiety
CBD
Systematic Review
N/A
2015
Anxiety
Dose related effects of THC on responses to psychosocial stress
THC
R, DB, PC
42
2017
Anxiety
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
CBD
R, DB, PC
24
2011
Anxiety
Effects of ipsapirone and cannabidiol on human experimental anxiety
CBD
DB, PC
40
1993
Dementia
Prescription of a THC/CBD-Based Medication to Patients with Dementia: A Pilot Study in Geneva
THC/CBD
Observational Study
10
2019
Epilepsy
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
CBD
Systematic Review
N/A
2019
Epilepsy
Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)
CBD
Clinical Trial Results
225
2018
General
Nabilone for Agitation in Alzheimer’s Disease
Nabilone
R, DB, CO
39
2020
Multiple Sclerosis
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
THC
R, DB, PC, CO
30
2012
Multiple Sclerosis
Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
THC:CBD
R, DB, PC, CO
57
2004
Psychiatric Disorders
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
THC, CBD
Systematic Review
N/A
2020
Psychiatric Disorders
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
THC, CBD, THC:CBD
Systematic Review
N/A
2019
Psychiatric Disorders
Cannabidiol as a potential treatment for psychosis
CBD
Systematic Review
N/A
2019
Psychiatric Disorders
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
CBD
R, DB, PC, PG, Clinical Trial
33
2018
Psychiatric Disorders
Opposite Effects of THC and CBD on Brain Function and Psychopathology
THC, CBD
DB, PC
15
2009

+ Tolerability

Indication
Title
Cannabinoids
Type
Patients
Year
Open Source
Adverse Events
Adverse effects of medical cannabinoids: a systematic review
THC, CBD
Systematic Review
N/A
2008
Adverse Events
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS)
THC (plant)
Prospective Cohort Study
431
2015
Adverse Events
Nabiximols as an Agonist Replacement Therapy During Cannabis WithdrawalA Randomized Clinical Trial
CBD:THC (Nabiximols)
R, DB, PC, Clinical Trial
51
2014
Adverse Events
Medicinal Cannabis – Potential Drug Interactions
THC, CBD
Review
N/A
2018
Driving Impairment
Cannabis Effects on Driving Skills
THC
Review
N/A
2014
Drug-drug interactions
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
CBD
Summary
N/A
2019
Pregnancy
Cannabis Abuse or Dependence During Pregnancy: A Population-Based Cohort Study on 12 Million Births
THC
RS
12.5m
2018
Pregnancy
Effects of Maternal Marijuana and Cocaine Use on Fetal Growth
THC
PS
1,226
1989

+ Health Agency Reviews

Agency
Title
Cannabinoids
Type
Patients
Year
Open Source
Canada
Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the cannabinoids
THC, CBD
Position Paper
N/A
2018
Chronic/Neuropathic Pain
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives
THC, CBD
Position Paper
N/A
2016
Europe
European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management
THC, CBD
Position Paper
N/A
2018
Referenced by Medsafe
Cannabis: The Evidence for Medical Use
THC, CBD, Dronabinol, THC:CBD
Position Paper
N/A
2016

The Cannasouth Clinical Fact Finder™ is an online, searchable database which enables prescribers to search for clinical data involving medical cannabis. This was compiled from searches of the following online libraries, MEDLINE®, PublMed®, Scopus®, SciFinder®, Google Scholar® and Science Direct®.

We encourage health care practitioners to share and bookmark this page to help them gain knowledge and confidence in prescribing.

Medicinal Cannabis and Chronic Pain

As part of our ongoing commitment to providing resources, training, and medicinal cannabis prescriber education, here is a link to the Goodfellow Institute’s course about medicinal cannabis and chronic pain.

Once you have completed this short course you can print your certificate for one Continuing Professional Development (CPD) hour.

Regulations

Our Chief Science Officer, David Gill, spoke to the team at NZ Doctor about the regulations that came into effect on April 1 2020, and how medicinal cannabis products will be prescribed.
NZ Doctor Article – Medicinal Cannabis Regulations

Click on the link below to view the misuse of drugs (medicinal cannabis) regulations, which were released in December 2019 by the Ministry of Health.
Misuse of Drugs (Medicinal Cannabis) Regulations

Join